ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681645 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681645; 2) Community: the network communities that were significantly associated with the response to NSC 681645; 3) Molecule: the relationships between components within communities and NSC 681645; 4) MDR: the compounds that were significantly associated with the NSC 681645.

NSC Compound Enrichment Correlation
NSC 670664 Null 0.00104257542638397 0.028107717
NSC 683558 Camptothecin Derivative 0.00104257542638397 0.88229821
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00104257542638397 0.71787792
NSC 735037 Camptothecin Derivative 0.00104257542638397 0.85542542
NSC 93354 Null 0.00104257542638397 0.24242919
NSC 671002 Null 0.0013187520236934 0.70619831
NSC 3088 Chlorambucil 0.00134664791567076 0.77729081
NSC 374028 Camptothecin Derivative 0.00134664791567076 0.88133446
NSC 606498 Camptothecin Derivative 0.00134664791567076 0.74227605
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.00134664791567076 0.77956447
Total:67  Current:6    [First] [Prev] [Next] [Last]